177 related articles for article (PubMed ID: 23149258)
1. Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
Moya-Ortega MD; Alves TF; Alvarez-Lorenzo C; Concheiro A; Stefánsson E; Thorsteinsdóttir M; Loftsson T
Int J Pharm; 2013 Jan; 441(1-2):507-15. PubMed ID: 23149258
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
Loftsson T; Hreinsdóttir D; Stefánsson E
J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of γ-cyclodextrin nanoparticle suspension eye drops in tear fluid.
Jóhannesson G; Moya-Ortega MD; Ásgrímsdóttir GM; Lund SH; Thorsteinsdóttir M; Loftsson T; Stefánsson E
Acta Ophthalmol; 2014 Sep; 92(6):550-6. PubMed ID: 24373641
[TBL] [Abstract][Full Text] [Related]
5. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
[TBL] [Abstract][Full Text] [Related]
6. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of a ricinoleic acid poloxamer gel system for transdermal eyelid delivery.
Boddu SH; Gupta H; Bonam SP
Int J Pharm; 2014 Aug; 470(1-2):158-61. PubMed ID: 24813783
[TBL] [Abstract][Full Text] [Related]
12. Topical drug delivery to the eye: dorzolamide.
Loftsson T; Jansook P; Stefánsson E
Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
[TBL] [Abstract][Full Text] [Related]
13. gammaCD/HPgammaCD: synergistic solubilization.
Jansook P; Loftsson T
Int J Pharm; 2008 Nov; 363(1-2):217-9. PubMed ID: 18691643
[TBL] [Abstract][Full Text] [Related]
14. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
Zhang L; Zhang J; Wang L; Xia H
Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
Loftsson T; Stefánsson E
Acta Ophthalmol Scand; 2002 Apr; 80(2):144-50. PubMed ID: 11952479
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
[TBL] [Abstract][Full Text] [Related]
17. New vehicle based on a microemulsion for topical ocular administration of dexamethasone.
Fialho SL; da Silva-Cunha A
Clin Exp Ophthalmol; 2004 Dec; 32(6):626-32. PubMed ID: 15575833
[TBL] [Abstract][Full Text] [Related]
18. CDs as solubilizers: effects of excipients and competing drugs.
Jansook P; Loftsson T
Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
[TBL] [Abstract][Full Text] [Related]
19. Latanoprost-loaded cyclodextrin microaggregate suspension eye drops for enhanced bioavailability and stability.
Zhou X; Li X; Xu J; Cheng Y; Cao F
Eur J Pharm Sci; 2021 May; 160():105758. PubMed ID: 33588044
[TBL] [Abstract][Full Text] [Related]
20. Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops.
Jansook P; Muankaew C; Stefánsson E; Loftsson T
Pharm Dev Technol; 2015; 20(5):626-32. PubMed ID: 24754413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
